Results 31 to 40 of about 13,870 (205)

Spectrophotometric method for analysis of metformin hydrochloride

open access: yesIndian Journal of Pharmaceutical Sciences, 2009
A simple and sensitive spectrophotometric method has been developed and validated for the estimation of metformin hydrochloride in bulk and in tablet formulation. The primary amino group of metformin hydrochloride reacts with ninhydrin in alkaline medium to form a violet colour chromogen, which is determined spectrophotometrically at 570 nm.
Mubeen, G., Noor, Khalikha
openaire   +3 more sources

Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin [PDF]

open access: yes, 2020
High expression of Ki67, a proliferation marker, is associated with reduced endometrial cancer-specific survival. Pre-surgical metformin reduces tumour Ki-67 expression in some women with endometrial cancer. Metformin's anti-cancer activity may relate to
Crosbie, EJ   +9 more
core   +2 more sources

Formulation and Evaluation of Multilayered Tablets of Pioglitazone Hydrochloride and Metformin Hydrochloride [PDF]

open access: yesJournal of Pharmaceutics, 2014
In the treatment of type 2 diabetes mellitus a continuous therapy is required which is a more complex one. As in these patients there may be a defect in both insulin secretion and insulin action exists. Hence, the treatment depends on the pathophysiology and the disease state.
Chowdary, Y. Ankamma   +2 more
openaire   +2 more sources

Assessment of Taste and Grittiness of Riomet® ER Strawberry, Riomet® ER Grape, Riomet® Cherry, and Metformin Immediate-Release Tablets in Healthy Subjects

open access: yesDrugs in R&D, 2019
Objective This study was conducted to evaluate the taste and grittiness of two formulations of Riomet® ER (metformin hydrochloride for extended release [ER] oral suspension 100 mg/mL) differing only in their flavoring agents (strawberry and grape) in ...
Allyson C. Marshall   +3 more
doaj   +1 more source

An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits

open access: yesBMC Veterinary Research, 2021
Background Metformin hydrochloride is a biguanide derivative that has been widely used to treat type 2 diabetes in humans. In veterinary medicine, metformin has shown increasing potential for diabetes treatment in different species, such as equids, dogs,
Sihem Bouriche   +4 more
doaj   +1 more source

Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery [PDF]

open access: yes, 2016
The combination of metformin hydrochloride (MTF) and glipizide (GLZ) is second-line medication for diabetes mellitus type 2 (DMT2). In the present study, elementary osmotic pump(EOP)tablet is designed to deliver the combination of MTF and GLZ in a ...
Chen, Tianbao   +4 more
core   +1 more source

Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2 [PDF]

open access: yes, 2014
The antiglycemic drug metformin, widely prescribed as first-line treatment of type II diabetes mellitus, has lifespan-extending properties. Precisely how this is achieved remains unclear.
Billen, Johan   +8 more
core   +1 more source

Towards Understanding the Structure, Dynamics and Bio-activity of Diabetic Drug Metformin

open access: yes, 2018
Small molecules are often found to exhibit extraordinarily diverse biological activities. Metformin is one of them. It is widely used as anti-diabetic drug for type-two diabetes.
Bagchi, Biman   +4 more
core   +1 more source

Phenformin, but not metformin, delays development of T-cell acute lymphoblastic leukemia/lymphoma via cell-autonomous AMPK activation [PDF]

open access: yes, 2019
Summary: AMPK acts downstream of the tumor suppressor LKB1, yet its role in cancer has been controversial. AMPK is activated by biguanides, such as metformin and phenformin, and metformin use in diabetics has been associated with reduced cancer risk ...
Atrih, Abdelmadjid   +10 more
core   +4 more sources

Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival. [PDF]

open access: yes, 2018
Pancreatic ductal adenocarcinoma (PDAC) is generally a fatal disease with no efficacious treatment modalities. Elucidation of signaling mechanisms that will lead to the identification of novel targets for therapy and chemoprevention is urgently needed ...
Eibl, Guido   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy